This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Diet in renal disease

Authoring team

The renal diet is:

  • low in phosphate (6.5 mg/kg/day)
  • low in potassium (0.6 g/kg/day)
  • low in protein
  • high in fibre
  • low in water soluble vitamins and so careful supplementation is indicated

A meta-analysis of published randomised controlled trials has revealed that 'dietary protein restriction reduces the risk of renal failure or death in nondiabetic renal disease and improves nephropathy in insulin-dependent diabetes mellitus' (1).

A systematic review found that (2):

  • reducing protein intake in patients with chronic kidney disease reduces the occurrence of renal death by 31% as compared with higher or unrestricted protein intake
  • optimal level of protein intake cannot be confirmed from the studies examined

NICE however state (3):

  • Do not offer low-protein diets (dietary protein intake less than 0.6-0.8 g/kg/day) to people with CKD

Reference:

  1. Fouque D. Meta-analysis: dietary protein restriction delays progression in renal disease. EBM 1 (5), 147.
  2. Fouque D et al. Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD001892.
  3. NICE (August 2021). Chronic kidney disease: assessment and management

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.